StockData
SNYRQOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31

Synergy CHC Corp.

Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on May 14, 2026
$0.01+0.00 (+5.26%)

Close on Oct 19, 2026

Market cap
$90.43K
P/E (TTM)
–
Dividend yield
–

Synergy CHC Corp. revenue by segment

By business segment

RevenueTTM Q1 26TTM Q4 25TTM Q3 25TTM Q2 25TTM Q1 25TTM Q4 24TTM Q3 24TTM Q2 24TTM Q4 23TTM Q1 20TTM Q4 19TTM Q3 19% of revenueYoY
Nutraceuticals [Member]–––––$33.39M––$42.75M$24.86M$28.15M$27.03M––
Cosmeceuticals [Member]–––––––––$216.39K$438.56K$594.04K––
License Revenue [Member]––––––––$24.58K$851.96K$706.69K$741.03K––
Over the Counter (OTC) [Member]–––––––––$76.34K$62.36K–––

By product or service

RevenueTTM Q1 26TTM Q4 25TTM Q3 25TTM Q2 25TTM Q1 25TTM Q4 24TTM Q3 24TTM Q2 24TTM Q4 23TTM Q1 20TTM Q4 19TTM Q3 19% of revenueYoY
Retail [Member]$20.55M$22.25M$22.06M$24.91M$25.90M$26.47M$31.72M$34.58M$31.78M$16.81M$18.97M$17.30M74.2%-20.7%
Online [Member]$7.16M$8.13M$9.62M$8.79M$7.69M$8.36M$6.06M$6.88M$11.00M$9.20M$10.38M$11.07M25.8%-7.0%
License Revenue [Member]–$2.90M––––––––––––

By region

RevenueTTM Q1 26TTM Q4 25TTM Q3 25TTM Q2 25TTM Q1 25TTM Q4 24TTM Q3 24TTM Q2 24TTM Q4 23TTM Q1 20TTM Q4 19TTM Q3 19% of revenueYoY
U.S [Member]$27.99M$27.32M$31.93M$31.26M$30.01M$30.83M$34.14M$37.74M$40.62M$24.65M$27.30M$25.89M101.0%-6.7%
Foreign countries [Member]–––$2.45M$3.59M$4.00M$3.64M$3.72M$2.16M$1.36M$2.06M$2.48M––

From the segment and revenue-disaggregation notes of Synergy CHC's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.